Florence Rozen is the Scientific Director, Private Equity and Impact Investing for life sciences with the Fonds de solidarité FTQ, a labour sponsored/development capital fund based in Montreal. There since 2009, she is responsible for scientific due diligence for all potential investment opportunities within the Fonds’ life science group. She is also responsible for monitoring the group’s biotech company portfolio, which covers areas such as oncology and rare diseases, as well as cardiovascular and metabolic diseases, all in different stages of development. Prior to her 24 years in the venture capital industry (including the seed financing arm of MDS Capital where she held similar responsibilities), she has done research in the fields of endocrinology and oncology. She holds a Ph.D. in biochemistry from McGill University.
